Cargando…
T021: Radiation-Free Therapy as the INitial treatment of Good-prognosis early non-bulky Hodgkin lymphoma, defined by a low Metabolic Tumor Volume and a negative PET-2 - RAFTING Trial.
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9642047/ http://dx.doi.org/10.1097/01.HS9.0000890652.56016.97 |
_version_ | 1784826219251892224 |
---|---|
author | Gallamini, Andrea Picardi, Marco Filonenko, Kateryna Gotti, Manuel Céspedes, Javier Núñez Rossi, Andrea Domingo-Domènech, Eva Giza, Agnieszka Sorasio, Roberto Trentin, Livio Oteiro, Mariana Bastos Paszkiewicz-Kozik, Ewa Sanz, Ramon García Patti, Caterina Chauvie, Stephane Bergesio, Fabrizio Guerra, Luca Rambaldi, Alessandro Balari, Ana Sureda Zaucha, Jan Maciej |
author_facet | Gallamini, Andrea Picardi, Marco Filonenko, Kateryna Gotti, Manuel Céspedes, Javier Núñez Rossi, Andrea Domingo-Domènech, Eva Giza, Agnieszka Sorasio, Roberto Trentin, Livio Oteiro, Mariana Bastos Paszkiewicz-Kozik, Ewa Sanz, Ramon García Patti, Caterina Chauvie, Stephane Bergesio, Fabrizio Guerra, Luca Rambaldi, Alessandro Balari, Ana Sureda Zaucha, Jan Maciej |
author_sort | Gallamini, Andrea |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9642047 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-96420472022-11-14 T021: Radiation-Free Therapy as the INitial treatment of Good-prognosis early non-bulky Hodgkin lymphoma, defined by a low Metabolic Tumor Volume and a negative PET-2 - RAFTING Trial. Gallamini, Andrea Picardi, Marco Filonenko, Kateryna Gotti, Manuel Céspedes, Javier Núñez Rossi, Andrea Domingo-Domènech, Eva Giza, Agnieszka Sorasio, Roberto Trentin, Livio Oteiro, Mariana Bastos Paszkiewicz-Kozik, Ewa Sanz, Ramon García Patti, Caterina Chauvie, Stephane Bergesio, Fabrizio Guerra, Luca Rambaldi, Alessandro Balari, Ana Sureda Zaucha, Jan Maciej Hemasphere Early Stages Lippincott Williams & Wilkins 2022-10-03 /pmc/articles/PMC9642047/ http://dx.doi.org/10.1097/01.HS9.0000890652.56016.97 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Early Stages Gallamini, Andrea Picardi, Marco Filonenko, Kateryna Gotti, Manuel Céspedes, Javier Núñez Rossi, Andrea Domingo-Domènech, Eva Giza, Agnieszka Sorasio, Roberto Trentin, Livio Oteiro, Mariana Bastos Paszkiewicz-Kozik, Ewa Sanz, Ramon García Patti, Caterina Chauvie, Stephane Bergesio, Fabrizio Guerra, Luca Rambaldi, Alessandro Balari, Ana Sureda Zaucha, Jan Maciej T021: Radiation-Free Therapy as the INitial treatment of Good-prognosis early non-bulky Hodgkin lymphoma, defined by a low Metabolic Tumor Volume and a negative PET-2 - RAFTING Trial. |
title | T021: Radiation-Free Therapy as the INitial treatment of Good-prognosis early non-bulky Hodgkin lymphoma, defined by a low Metabolic Tumor Volume and a negative PET-2 - RAFTING Trial. |
title_full | T021: Radiation-Free Therapy as the INitial treatment of Good-prognosis early non-bulky Hodgkin lymphoma, defined by a low Metabolic Tumor Volume and a negative PET-2 - RAFTING Trial. |
title_fullStr | T021: Radiation-Free Therapy as the INitial treatment of Good-prognosis early non-bulky Hodgkin lymphoma, defined by a low Metabolic Tumor Volume and a negative PET-2 - RAFTING Trial. |
title_full_unstemmed | T021: Radiation-Free Therapy as the INitial treatment of Good-prognosis early non-bulky Hodgkin lymphoma, defined by a low Metabolic Tumor Volume and a negative PET-2 - RAFTING Trial. |
title_short | T021: Radiation-Free Therapy as the INitial treatment of Good-prognosis early non-bulky Hodgkin lymphoma, defined by a low Metabolic Tumor Volume and a negative PET-2 - RAFTING Trial. |
title_sort | t021: radiation-free therapy as the initial treatment of good-prognosis early non-bulky hodgkin lymphoma, defined by a low metabolic tumor volume and a negative pet-2 - rafting trial. |
topic | Early Stages |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9642047/ http://dx.doi.org/10.1097/01.HS9.0000890652.56016.97 |
work_keys_str_mv | AT gallaminiandrea t021radiationfreetherapyastheinitialtreatmentofgoodprognosisearlynonbulkyhodgkinlymphomadefinedbyalowmetabolictumorvolumeandanegativepet2raftingtrial AT picardimarco t021radiationfreetherapyastheinitialtreatmentofgoodprognosisearlynonbulkyhodgkinlymphomadefinedbyalowmetabolictumorvolumeandanegativepet2raftingtrial AT filonenkokateryna t021radiationfreetherapyastheinitialtreatmentofgoodprognosisearlynonbulkyhodgkinlymphomadefinedbyalowmetabolictumorvolumeandanegativepet2raftingtrial AT gottimanuel t021radiationfreetherapyastheinitialtreatmentofgoodprognosisearlynonbulkyhodgkinlymphomadefinedbyalowmetabolictumorvolumeandanegativepet2raftingtrial AT cespedesjaviernunez t021radiationfreetherapyastheinitialtreatmentofgoodprognosisearlynonbulkyhodgkinlymphomadefinedbyalowmetabolictumorvolumeandanegativepet2raftingtrial AT rossiandrea t021radiationfreetherapyastheinitialtreatmentofgoodprognosisearlynonbulkyhodgkinlymphomadefinedbyalowmetabolictumorvolumeandanegativepet2raftingtrial AT domingodomenecheva t021radiationfreetherapyastheinitialtreatmentofgoodprognosisearlynonbulkyhodgkinlymphomadefinedbyalowmetabolictumorvolumeandanegativepet2raftingtrial AT gizaagnieszka t021radiationfreetherapyastheinitialtreatmentofgoodprognosisearlynonbulkyhodgkinlymphomadefinedbyalowmetabolictumorvolumeandanegativepet2raftingtrial AT sorasioroberto t021radiationfreetherapyastheinitialtreatmentofgoodprognosisearlynonbulkyhodgkinlymphomadefinedbyalowmetabolictumorvolumeandanegativepet2raftingtrial AT trentinlivio t021radiationfreetherapyastheinitialtreatmentofgoodprognosisearlynonbulkyhodgkinlymphomadefinedbyalowmetabolictumorvolumeandanegativepet2raftingtrial AT oteiromarianabastos t021radiationfreetherapyastheinitialtreatmentofgoodprognosisearlynonbulkyhodgkinlymphomadefinedbyalowmetabolictumorvolumeandanegativepet2raftingtrial AT paszkiewiczkozikewa t021radiationfreetherapyastheinitialtreatmentofgoodprognosisearlynonbulkyhodgkinlymphomadefinedbyalowmetabolictumorvolumeandanegativepet2raftingtrial AT sanzramongarcia t021radiationfreetherapyastheinitialtreatmentofgoodprognosisearlynonbulkyhodgkinlymphomadefinedbyalowmetabolictumorvolumeandanegativepet2raftingtrial AT patticaterina t021radiationfreetherapyastheinitialtreatmentofgoodprognosisearlynonbulkyhodgkinlymphomadefinedbyalowmetabolictumorvolumeandanegativepet2raftingtrial AT chauviestephane t021radiationfreetherapyastheinitialtreatmentofgoodprognosisearlynonbulkyhodgkinlymphomadefinedbyalowmetabolictumorvolumeandanegativepet2raftingtrial AT bergesiofabrizio t021radiationfreetherapyastheinitialtreatmentofgoodprognosisearlynonbulkyhodgkinlymphomadefinedbyalowmetabolictumorvolumeandanegativepet2raftingtrial AT guerraluca t021radiationfreetherapyastheinitialtreatmentofgoodprognosisearlynonbulkyhodgkinlymphomadefinedbyalowmetabolictumorvolumeandanegativepet2raftingtrial AT rambaldialessandro t021radiationfreetherapyastheinitialtreatmentofgoodprognosisearlynonbulkyhodgkinlymphomadefinedbyalowmetabolictumorvolumeandanegativepet2raftingtrial AT balarianasureda t021radiationfreetherapyastheinitialtreatmentofgoodprognosisearlynonbulkyhodgkinlymphomadefinedbyalowmetabolictumorvolumeandanegativepet2raftingtrial AT zauchajanmaciej t021radiationfreetherapyastheinitialtreatmentofgoodprognosisearlynonbulkyhodgkinlymphomadefinedbyalowmetabolictumorvolumeandanegativepet2raftingtrial |